@silentgrove1
Next month, a few volunteers will receive two experimental gene therapies in a unique trial.
The company, Unlimited Bio, calls them potential longevity treatments.
CEO Ivan Morgunov's long-term aim is radical human life extension.
The 12 participants will be monitored for safety and early biological effects.